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Summary
Objective: Articular cartilage contains mesenchymally derived chondroprogenitor cells that have the potential to be used for stem cell therapy.
The aim of this study was to characterise the growth kinetics and properties of in vitro expanded cloned chondroprogenitors and determine if
critical determinants of the progenitor phenotype were maintained or lost in culture.
Methods: Chondroprogenitors were isolated from immature bovine metacarpalphalangeal joints by differential adhesion to ﬁbronectin. Cloned
colonies were expanded in vitro up to 50 population doublings (PD). Growth characteristics were assessed by cell counts, analysis of telomere
length, telomerase activity, expression of senescence-associated b-galactosidase activity and real-time quantitative polymerase chain reac-
tion to analyse the gene expression patterns of sox9 and Notch-1 in chondroprogenitors.
Results: Cloned chondroprogenitors exhibited exponential growth for the ﬁrst 20 PD, then slower linear growth with evidence of replicative
senescence at later passages. Mean telomere lengths of exponentially growing chondroprogenitors were signiﬁcantly longer than dedifferen-
tiated chondrocytes that had undergone a similar number of PD (P< 0.05). Chondroprogenitors also had 2.6-fold greater telomerase activity.
Chondroprogenitors maintained similar sox9 and lower Notch-1 mRNA levels compared to non-clonal dedifferentiated chondrocytes. Chon-
droprogenitors were induced to differentiate into cartilage in 3D pellet cultures, immunological investigation of sox9, Notch-1, aggrecan and
proliferating cell nuclear antigen (PCNA) expression showed evidence of co-ordinated growth and differentiation within the cartilage pellet.
Conclusion: Clonal chondroprogenitors from immature articular cartilage provide a useful tool to understand progenitor cell biology from the
perspective of cartilage repair. Comparisons with more mature progenitor populations may lead to greater understanding in optimising repair
strategies.
ª 2008 Osteoarthritis Research Society International. Published by Elsevier Ltd. All rights reserved.
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The use of stem/progenitor cells whose progeny have the
capacity to form good quality cartilage matrix has been tar-
geted as a therapeutic goal for the treatment of large
defects of articular cartilage that may result from serious
trauma or widespread osteoarthritic lesions. Currently,
smaller more localised lesions have been treated with ex-
panded mature chondrocytes harvested autologously and
expanded in monolayer culture1e4. A major limiting factor
of this technique is that the size of defect to be treated is
dependent on the amount of cells that can be generated
from the harvested cartilage taken from the joint periphery.
The reason for this limitation is that during expansion in
monolayer culture, chondrocytes undergo progressive
non-chondrogenic phenotypic modulation as a function of
mitotic index and, in human chondrocytes, are unable to
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518doublings (PD), even under permissive pellet culture condi-
tions where the characteristic rounded morphology of the
chondrocytes is re-established5e8. Although the number of
cell cycles can be extended somewhat by addition of ﬁbro-
blast growth factor-2, the generation of large cell numbers is
problematic. Consequently, there is a clinical need for in-
creasing cell yield whilst maintaining chondrogenic potential
in order to address the treatment of larger cartilage defects.
We have previously reported on the isolation and partial
characterisation of a progenitor cell population that resides
in the surface layer of neonatal bovine articular cartilage9.
Here, we report on the long-term clonal expansion of the pro-
genitor cells in monolayer culture and assess their chondro-
genic potential as a function of their ability to elaborate
a cartilage matrix in pellet cultures, maintenance of sox9 ex-
pression, analysis of telomere length and telomerase activity.
Materials and methodsISOLATION AND CULTIVATION OF CHONDROPROGENITOR
CLONESChondroprogenitor cells were isolated on the basis of differential adhesion to
ﬁbronectin as previously described in Dowthwaite et al.9 Firstly, surface-zone
chondrocytes were isolated by surgical dissection from the metacarpalphalan-
geal (MCP) joints of 7-day-old juvenile bovine steers and subjected to sequential
519Osteoarthritis and Cartilage Vol. 17, No. 4pronase, collagenase enzymatic digestion. Isolated chondrocytes were sub-
jected to differential adhesion on ﬁbronectin-coated 60 mm dishes for 20 min
in 4 ml 1:1 Dulbecco’s modiﬁed eagles medium (DMEM)/F12 plus 10% foetal
calf serum (Invitrogen, UK) at a concentration of 700 cells ml1. After 20 min,
media and non-adherent cells were removed and replacedwith standard growth
media. Cultured cells were maintained in a humidiﬁed 37C, 5% CO2 incubator
for 6 days. Colonies of>32 cells (chondroprogenitor clones) were isolated using
cloning rings and replated in 35 mm culture dishes and further expanded. En-
riched (polyclonal) populations of chondroprogenitors were culture expanded
from the 60 mm dishes used in the initial adhesions. Full-depth and superﬁcial
zone cells were enzymatically isolated using surgical dissection from the MCP
joints. Cells were passaged in T25 culture dishes and on reaching conﬂuence
were trypsinised and replated at a ratio of 1:10. Cell counts were recorded at
the end of every passage and the number of PD calculated using the following
equation: PD¼ log10(N/N0) 3.33, where N0 is the initial number of cells
seeded and N is the number of cells at the end of the passage.CHONDROPROGENITOR PELLET CULTUREChondroprogenitor clones (average 30 PD, n¼ 6) were pelleted at a concen-
trationof 1 106 cellsper1.5 mlEppendorf centrifuge tubeandgrown inchondro-
genic medium; DMEM/F12, 1% insulinetransferrineselenium supplement
(Sigma), 10 mM 4-(2-hydroxyethyl)-1-piperazineethanesulfonic acid (HEPES)
pH 7.4, 0.1% gentamicin, 0.1 mMdexamethasone and10 ng transforming growth
factor b1 (TGFb1) (PeproTech EC Ltd., London, UK). The chondrogenicmedium
was replaced every other day and pellet culturesmaintained for a total of 21 days.TELOMERE-LENGTH ASSAYTelomere lengths of samples were detected using the TeloTAGGG telo-
meric length assay kit (Roche Diagnostics, Sussex, UK). The mean telomere
length of samples was obtained by scanning the exposed X-ray ﬁlm with
a densitometer within the linear range of the ﬁlm. Each lane was split into
30 equally spaced squares (i) and the optical density (OD) within each
square was obtained as well as the molecular weight at the mid point of
the corresponding square. The telomere length was then calculated using
the expression, mean telomere length¼P(ODi)/
P
(ODi /Li).REAL-TIME QUANTITATIVE TELOMERE REPEAT AMPLIFICATION
PROCEDURE (RTQ-TRAP)Comparative quantitative analysis of telomerase activity in samples was
performed using a previously validated RTQ-TRAP methodology10. Cells
were lysed at a concentration of 1 106 per 200 ml of lysis buffer; 10 mM
Tris pH 8.3, 1.5 mM MgCl2, 1 mM ethylene glycol tetraacetic acid (EGTA),
10% glycerol, 0.5% 3[(3-Cholamidopropyl)dimethylammonio]-propanesul-
fonic acid buffer, 1 mM phenylmethanesulphonylﬂuoride, 5 mM b-mercaptoe-
thanol and 200U RNAsin. Each reaction comprised 1 SYBR Green
Mastermix (Eurogentec Ltd., Hampshire, UK), 10 mM EGTA, 0.2 mg T4
gene protein, 0.3 mM primers TS (50-AAT CCG TCG AGC AGA GTT-30)
and ACX (50-GCG CGG [CTT ACC]3 CTA ACC-30) and 25 103 cells in a ﬁ-
nal volume of 25 ml. The reaction mixture was incubated for 25C for 20 min
to allow the telomerase to extend the TS primer, heated to 95C for 10 min to
activate Taq Polymerase, followed by 40 cycles at 95C for 20 s, 50C for
30 s and 72C for 90 s. Telomerase activity in cell samples was calculated
based on the threshold cycle (CT). All samples were run in triplicate and lysis
buffer was used as a negative control. Immortal human leukaemia cell line
HL60 was used as a cell-line positive for telomerase activity. HL60 cell ex-
tracts were serially diluted and assayed by RT-TRAP to generate a standard
curve that was used to derive telomerase activity units based on the number
of input cell equivalents.DETECTION OF SENESCENT-ASSOCIATED b-GALACTOSIDASE
(SA b-GAl) ACTIVITYSenescence was detected by observation of endogenous b-galactosi-
dase (b-Gal) activity at pH 6.0. Cells were ﬁxed in 2% formaldehyde/glutar-
aldehyde for 4 min, and then incubated (18 h, 37C) in reaction mix (40 mM
citric acid/phosphate-buffered salts (PBS) pH 6.0, 1 mg/ml X-Gal, 5 mM po-
tassium ferricyanide, 150 mM NaCl, 2 mM MgCl2)
11. Senescent cells stained
blue. Results were expressed as the percentage of positively labelled cells.
A total of four random ﬁelds of view from each dish were examined.REAL-TIME POLYMERASE CHAIN REACTION (PCR)
AMPLIFICATION AND QUANTITATIVE ANALYSISQuantitative polymerase chain reaction (qPCR) using the ﬂuorescent dye
SYBR Green (Eurogentec, Belgium) was used to determine the absoluteexpression levels of collagen type II, aggrecan, sox9, HES-1 and Notch-1 be-
tween different cell populations. The PCR products from reactions containing
the following primer pairs; sox9 (forward: AAC GCC GAG CTC AGC AAG,
reverse: ACG AAC GGC CGC TTC TC), Notch-1 (forward: TGA GCA
CGC GGG CAA GTG CAT, reverse: TGC AGA CAC TGG CAC TCG A),
Hairy Enhancer of Split-1 (HES-1; forward: GCC TCC ACC TAA ACG ACT
CA, reverse: TTG ATC CCC CTC GCT CTT TTA) and 18S rRNA primers,
were cloned and sequenced to conﬁrm their identities. The sequences of col-
lagen type II, 18S and aggrecan primers have been previously published12.
Real-time PCR reactions were carried out in 25 ml volumes in a 96-well plate
(Applied Biosystems) containing 1 buffer (10), 3.5 mM MgCl2, 200 mM
dNTPs, 0.3 mM of sense and antisense primers, 0.025 U/ml enzyme and
1:66000 SYBR GreenI. All reactions were made using qPCR Core Kit
for SYBR Green I (Eurogentec). At the end of each reaction, the cycle
threshold (CT) was manually setup at the level that reﬂected the best kinetic
PCR parameters, and melting curves were acquired and analysed. Absolute
values for the gene of interest were calculated from standard curves gener-
ated using serially diluted plasmid cloned and sequence veriﬁed template (ng
DNA) and were normalised to the housekeeping gene 18S rRNA. Relative
expression levels for monitoring sox9 levels between chondroprogenitor
clones at increasing passages were determined using the DDCT method.ANTIBODY LABELLING OF CHONDROPROGENITOR PELLETSWax embedded tissue blocks of 4% paraformaldehyde ﬁxed chondropro-
genitor pellets were cut to generate 8 mm sections, mounted onto coated
slides and processed for immunodetection of proteins. Primary antibodies,
monoclonal anti-rat Notch-1 (bTan20, Developmental Studies Hybridoma
Bank, Iowa, USA), monoclonal anti-bovine aggrecan (2B6), monoclonal
anti-mouse proliferating nuclear antigen (PCNA; PC10, Sigma) and rabbit
anti-sox9 (ab3697, Abcam, UK) were diluted in tris-buffered salts (TBS) at
a concentration of 5 mgml1 and sections probed for 12 h at 4C. Sections
were probed with either anti-goat peroxidase-conjugated or ﬂuorescein iso-
thiocyanate (FITC)-conjugated anti-rabbit and anti-mouse secondary anti-
bodies (Sigma). Peroxidase-conjugated antibodies were detected on
sections using colour substrate (Vector SG, Vectorlabs) and then counter-
stained for 30 s in 0.1% Safranin-O. Fluorescently labelled sections were
mounted in Vectashield (VectorLabs) containing 40,6-diamidino-2-phenylin-
dole (DAPI) as a counterstain for cell nuclei and viewed using an Olympus
BX61 ﬂuorescence microscope. We used goat, mouse and rabbit serum at
the same concentrations as the primary antibodies to control non-speciﬁc la-
belling in sections.STATISTICAL ANALYSISThe data are reported as mean standard deviation of the indicated num-
ber of experimental values. All datasets were assessed for normal population
distribution using the ShapiroeWilk test, and homogeneity of variance using
Levene’s test. One-way analysis of variance (ANOVA) was used to compare
means of datasets that met all the assumptions of this test, followed by post
hoc pairwise comparisons using the method of Bonferroni. Where assump-
tions for ANOVA were not met, non-parametric KruskaleWallis ANOVA
was employed using ManneWhitney U tests for subsequent pairwise com-
parisons. In all cases, P< 0.05 was considered statistically signiﬁcant. All
experiments were repeated at least twice.Results
Clonally derived chondrocyte progenitor cells were iso-
lated from juvenile bovine chondrocytes using differential
adhesion to ﬁbronectin and expanded in monolayer culture.
Clonal chondroprogenitor morphology after increasing PD
was recorded, Fig. 1(A). Early passage chondroprogenitors
were small and polygonal, whereas after extended mono-
layer cultivation (45 PD) progenitor cell bodies had enlarged
signiﬁcantly and were multipolar, Fig. 1(A).
The growth kinetics of chondroprogenitor clones (n¼ 8)
was investigated beginning from their isolation as colonies
of greater than 33 cells through to 17 passages correspond-
ing to an average of 47 4.4 PD, Fig. 1(B). Passage-1 cul-
tures reached conﬂuence within 2 weeks undergoing on
average 20 2.3 PD, displaying a doubling time of less
than 24 h reﬂecting the time progenitors were under the in-
ﬂuence of rapid growth. During subsequent passaging, pro-
genitor clone proliferation rates slowed to 3e4 days per PD,
which with further cultivation declined to 1 PD per week. At
Fig. 1. Growth kinetics and morphology of clonal chondroprogenitors following expansion in monolayer culture. (A) Early passage chondro-
progenitors (5 PD) were small, polygonal and possessed a ﬂattened morphology on dishes. Late passage chondroprogenitors (45 PD) adop-
ted a larger, irregular, multi-stellate ﬁbroblastic morphology. Scale bar¼ 100 mm. (B) The growth kinetics of eight chondroprogenitor clones
was investigated from primary culture through 17 passages corresponding to an average 47 4.4 PD. Passage-1 cultures reached conﬂu-
ence after 2 weeks on average, on replating the clones slowed their proliferation rate, with a growth rate of about 3e4 days per PD. With
further cultivation the growth rate slowed to around 1 PD per week. The early growth phase of non-clonal dedifferentiated chondrocytes is
also shown for comparison.
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a plateau in growth rate, which was accentuated by
50 PD when morphological evidence of cellular senescence
characterised by enlarged, ﬂattened and heterogeneous
shaped cells was present. Non-clonal full-depth chondro-
cytes that were expanded under identical conditions to
that for chondroprogenitor cells demonstrated linear growth
kinetics, Fig. 1(B).
Early passage chondroprogenitor clones (w10 PD) ex-
hibited positive labelling for lysosomal b-Gal activity that is
optimal at pH 4 but were negative for SA b-Gal that is opti-
mally active at pH 6, Fig. 2. In contrast approximately 10%
of late passage chondroprogenitors (39e40 PD) labelled
positively for the presence of SA b-Gal. However, we found
no statistically signiﬁcant difference in b-Gal activity be-
tween late passage chondroprogenitor and late passage
dedifferentiated chondrocytes.In order to determinewhether the underlyingmechanismof
progenitor-associated senescence was telomere-length de-
pendent we analysed the mean telomere lengths of freshly
isolated chondrocytes, low-passage chondroprogenitors
(22 PD), mid-passage chondroprogenitors (32 PD) and
non-clonal dedifferentiated chondrocytes that had under-
gone 21 PD, Fig. 3(A). There was no difference in mean telo-
mere lengths between unpassaged full-depth or surface
chondrocytes and low-passage chondroprogenitors. All
three latter cell populations had signiﬁcantly (P< 0.05;
n¼ 3) longermean telomere lengths thanmid-passagechon-
droprogenitors and dedifferentiated chondrocytes, Fig. 3(B).
Further, we analysed telomerase activities of individual cell
populations using a real-time TRAP assay, Fig. 4(AeF).
Low-passage chondroprogenitors exhibited greater telome-
rase activity than either full-depth or superﬁcial zone chon-
drocytes (mean threshold cycle (CT); full-depth 26.5 0.7,
Fig. 2. Photomicrographs of cultures stained for senescence-associated b-galactosidase activity (SA b-Gal). Early passage clonal chondro-
progenitors, 10 PD, expressed positive lysosomal b-Gal labelling (pH4; upper left panel ) but did not label positive for senescence-associated
b-Gal (SA b-Gal; pH6; upper right panel ). SA b-Gal was detected in late passage, 39 PD and 40 PD chondroprogenitor clones (lower panels).
Scale bar¼ 100 mm.
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22.0 0.2, P< 0.05; n¼ 4), Fig. 4(C, D). When converted
into HL60 cell equivalent units chondroprogenitors had 2.6-
fold more telomerase activity than full-depth or superﬁcial
zone chondrocytes, Fig. 4(E). In a separate experiment, we
analysed telomerase activity between low and mid-passage
chondroprogenitors and observed that mid-passage cells
displayed greater variation in values and showed a lower
trend for the mean, Fig. 4(F), implying possible dysregulation
of telomerase activity in some clones with increasing age.
qPCR analysis of type II collagen and aggrecan gene ex-
pression showed that both clonal chondroprogenitors and
non-clonal dedifferentiated chondrocytes have very low but
detectable mRNA message levels, respectively, compared
to the reference standard of full-depth chondrocytes,
Fig. 5(A). Analysis of Notch-1 mRNA message levels
showed dedifferentiated chondrocytes expressed signiﬁ-
cantly more message than parental full-depth chondrocytes
(3.5-fold; P< 0.001; n¼ 4) or chondroprogenitor clones
(twofold; P¼ 0.012; n¼ 4). We found HES-1 expression in
chondroprogenitor populations was 3.68-fold higher than in
the parental chondrocyte population (P¼ 0.009) though
there was no difference when compared to message levels
in dedifferentiated chondrocytes, Fig. 5(A). sox9 message
levels were lower in both clonal chondroprogenitor (3.5-
fold; P< 0.001; n¼ 4) and dedifferentiated chondrocytes
(7.7-fold; P< 0.0001; n¼ 4) compared to full-depth unpas-
saged cells. Within the clonally derived chondroprogenitor
populations, no signiﬁcant differences were present in rela-
tive sox9 message levels following culture expansion
between 18 PD and 45 PD, Fig. 5(B). In chondroprogenitor-
enriched (polyclonal) cultures, there was a signiﬁcant
reduction in the relative quantities of sox9 mRNA resulting
in a 50-fold reduction in expression levels by 40 PD (foldinduction: 10 PD 1 0.7, 12 PD 1.3 1.1, 35 PD
0.07 0.06, 40 PD 0.02 0.05; P< 0.05; n¼ 8, 9, 4 and 9,
respectively).
We conducted an immunoﬂuorescence study to deter-
mine if Notch-1 and sox9 protein levels correlated with
mRNA message levels, Fig. 6. We observed reduced label-
ling for sox9 and Notch-1 in dedifferentiated chondrocytes
and chondroprogenitor cells compared to unpassaged
freshly isolated chondrocytes. We saw evidence of perinu-
clear labelling for sox9 and diffuse cellular labelling with
Notch-1 antibodies in clonal and non-clonal dedifferentiated
chondrocytes.
In order to determine whether chondroprogenitor clones
maintain an ability to form cartilage after expansion, chon-
droprogenitor clones isolated from six different donors and
harvested at 30 PD were cultured as high-density pellets
in the presence of chondrogenic medium. All formed
chondrocyte pellets and all stained positively for the meta-
chromatic histochemical dye Safranin-O, Fig. 7(A) (repre-
sentative image shown). The inner zone of pellets was
cell-dense and the nuclei stained red with Safranin-O com-
pared to the outer zone where the intervening extracellular
matrix stained orange-red, displaying metachromasia, evi-
dence for the presence of sulphated proteoglycans,
Fig. 7(A). Notch-1 labelling was present in a band of cells
of the inner zone of the pellet, spreading outwards up to
the boundary where the cells:matrix ratio was lower and
where aggrecan labelling, marking differentiated chondro-
progenitors, was present. Proliferating cell nuclear antigen
(PCNA) protein was also detected in the nucleus of cells
located in a band around the pellet at the outer margin
of Notch-1 expression. sox9 was localised to undifferenti-
ated chondroprogenitors within the pellet (labelling in-
tensely at the margin between non-differentiated and
Fig. 3. Telomere-length analysis of chondrocytes and chondropro-
genitor clones. (A) Southern blot analysis of telomere lengths of re-
striction enzyme digested DNA of full-depth articular cartilage
chondrocytes (FD), surface-zone chondrocytes (S), chondroproge-
nitor clones (CP) that had undergonew22 PD orw32 PD, and de-
differentiated chondrocytes (ddC, w21 PD). Genomic DNA with
known telomere length (H¼ 10.2 kb, L¼ 3.9 kb) was used as an in-
ternal control. (B) Bar plot of mean telomere lengths of chondrocyte
cell populations (P< 0.05; n¼ 3).
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of the pellet. At higher magniﬁcation we observed that
sox9 had cytoplasmic and nuclear subcellular distribution
in cells of the peripheral zone, whereas in cells within
the inner zone sox9 subcellular localisation was predomi-
nately but not exclusively nuclear, Fig. 7(B). Chondropro-
genitor cells lying in the centre of pellets were Notch-1
negative and are also aggrecan negative, and using
DAPI staining a high proportion of these cells appeared
necrotic and apoptotic, probably due to nutritional deﬁcit
and hypoxia.Discussion
The current study extends our knowledge of the biology of
articular cartilage progenitor cells signiﬁcantly especially in
relation to their cell growth characteristics and maintenance
of chondrogenicity following extendedmonolayer expansion.
The progenitor status of the cells is reinforced by their limitedgrowth potential, evidence of senescence between 40 PD
and 50 PD, and continued expression of sox9 and mainte-
nance of telomere ends during early passages.
Telomeres are highly conserved sequences at the end of
chromosomes and consist in part of a large number of re-
peat based on the sequence motif (TTAGGG)n
13. At every
round of cellular division, due to the ‘end replication prob-
lem’ where the lagging strand is incompletely synthesised
as double-stranded DNA, telomeres are known to shorten
by approximately 50e200 bp14. We observed that chondro-
progenitors maintained their average telomere length, dis-
playing no diminution even after 22 PD when compared to
unpassaged parental cells. The telomere erosion rate of
chondroprogenitors during this early growth phase, deﬁned
as the change in average telomere length as a function of
the number of times the cell population has doubled, is
4.5 bp per PD; dedifferentiated chondrocytes have a telo-
mere erosion rate of 166 bp per PD. When chondroprogeni-
tors exit exponential growth (between 22 and 32 PD) their
telomere erosion rate approaches a value, 139 bp per PD,
comparable to that of non-clonal cells. Therefore telomere
erosion occurs as a function of growth kinetics. It is known
that telomere erosion is exacerbated in heterogeneous
asynchronous cell populations, essentially what the non-
clonal dedifferentiated chondrocyte population is initially
composed of, through the assumption that cohorts of cells
within the total population divide more often and therefore
have shorter telomeres as a result15. Synchronous expo-
nential growth of a homogeneous cell population is known
to result in lower erosion rates although this cannot wholly
explain such a large reduction in telomere erosion rates in
chondroprogenitor cells. Telomerase is a reverse-transcrip-
tase complex that adds telomeric repeats to the ends of
eukaryotic chromosomes16. We discovered that chondro-
progenitors possess 2.6-fold more telomerase activity than
unpassaged chondrocytes whereas dedifferentiated chon-
drocytes have no detectable activity. Therefore we believe
the transient maintenance of telomere ends in chondropro-
genitors during the early growth phase is promoted in part
by the activity of telomerase. Studies have also shown
that exogenous expression of telomerase in human osteo-
arthritis (OA) chondrocytes by retroviral transfection signiﬁ-
cantly extends the expansion potential of these cells
beyond 25 PD and promotes redifferentiation17. Therefore,
maintenance of telomere length during extended culture ex-
pansion may potentially contribute to enhanced repair due
to protection from replicative stress. Analysis of human ar-
ticular chondrocytes undergoing in vitro culture growth
has shown that an 8e10-fold expansion (w3 PD, typical
for transplantation procedures) is equivalent to approxi-
mately 30 years of aging18, which could have a contributory
impact on the efﬁciency of repair of cartilage defects as so
many underlying factors impeding repair are age-related19.
Even the presence of a small cohort of senescent cells
within a expanded cell population can have negative impli-
cations for cartilage repair, as senescent cells can adopt
a catabolic or pro-inﬂammatory phenotype, for example,
senescent ﬁbroblasts upregulate the expression of matrix-
metalloproteinases such as collagenase that actively de-
grade the extracellular matrix20. Therefore the extent of
cell expansion has to be carefully controlled to avoid artiﬁ-
cial aging of cells in vitro. The role of telomerase is not re-
stricted solely to polymerisation of telomeric DNA,
telomerase also inﬂuences cell-fate decisions and exerts
transcriptional control on the glycolytic pathway, although
these observations are restricted as yet to melanocytes
and melanomas21.
Fig. 4. Real-time quantitative telomere repeat ampliﬁcation procedure (RTQ-TRAP) analysis of telomerase activity in chondrocyte cell popu-
lations. (A) Serially diluted protein extracts made from the human leukaemia cell HL60 were used to derive a linear relationship between the
input cell number and CT values. The log of change in ﬂuorescence intensity shown in the y-axis was plotted against cycle number (all sam-
ples run in triplicate). (B) A linear relationship between the log of cell number vs threshold cycle was observed. (C) RTQ-TRAP analysis of
exponential phase chondroprogenitor (CP), full-depth (FD) and superﬁcial zone (S) chondrocytes. The plot shows clear segregation between
CP and FDeS samples (highlighted ) in their threshold cycle (CT) values. (D) Graph of CT values for chondrocyte populations is shown
(P< 0.05; n¼ 4). (E) Conversion of CT values into HL60 cell equivalents; chondroprogenitors show a 2.6-fold greater activity than parental
cells. (F) Comparison of telomerase activity between early- and mid-passage culture expanded chondroprogenitors.
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Fig. 5. Real-time quantitative PCR gene expression analysis of chondrocyte and chondroprogenitor cell populations. (A) Complementary DNA
from chondroprogenitors, full-depth (FD), clonally derived (CP) and dedifferentiated chondrocytes (ddC) was analysed using qPCR to deter-
mine the absolute gene expression levels (*P< 0.05; n¼ 4). All y-axes represent gene expression levels normalised to 18S rRNA. (B) Relative
gene expression of sox9 between expanded chondroprogenitor clones covering 18e45 PD (n¼ 8) and enriched (polyclonal) chondroproge-
nitors (eCP) between 10 PD and 40 PD (n¼ 8, 9, 4 and 9, respectively) was determined using the DDCT method.
Fig. 6. Immunoﬂuorescent labelling for sox9 and Notch-1 proteins in freshly isolated full-depth chondrocytes (FD), dedifferentiated (ddC,
22 PD) and chondroprogenitor (CP, 21 PD) cells. Cells were grown on glass coverslips for 24 h then processed for immunoﬂuorescent de-
tection of sox9 and Notch-1 antibody labelling using FITC-conjugated secondary antibodies and propidium iodide as a nuclear counterstain.
Representative data from three separate labellings. Positive labelling for Notch-1 and sox9 was present in FD cells (arrowed) and only weakly
observed in ddC and CP cells. No labelling was present in control sections incubated without primary antibody, or, with rabbit or goat immu-
noglobins (data not shown). Magniﬁcation: 400.
525Osteoarthritis and Cartilage Vol. 17, No. 4sox9 mRNA and protein levels were maintained in chon-
droprogenitor clones and dedifferentiated chondrocytes
alike throughout their expansion in monolayer culture. Mes-
sage levels of sox9 were approximately 3.5- and 7-fold
reduced in chondroprogenitor and dedifferentiated chondro-
cytes, respectively, compared to freshly isolated chondro-
cytes. The presence of sox9 probably account in part for
the expedient transition of dedifferentiated chondroprogeni-
tors to form high-density cartilage cultures. sox9 messages
levels are similarly maintained in passaged articular chon-
drocytes obtained from skeletally mature bovine joints (un-
published observations), therefore, discounting the age of
donor as a factor in the maintenance in its expression.
sox9 is maintained during monolayer culture in passaged
human foetal chondrocytes22 as well as in passaged human
OA chondrocytes23, although in the latter case retroviral ex-
pression of sox9 in passaged OA chondrocytes allows the
recovery of chondrocytic capacity comparable to that of nor-
mal healthy chondrocytes, supporting the notion that contin-
uous sox9 expression directly or indirectly maintains
chondrogenicity23. Lineage tracing using sox9-ires-Cre
knock-in mice crossed with ﬂoxed LacZ rosa26 mice
show sox9 expressing cells give rise to progenitor cells in
cartilage, bone, tendon, synovium, spinal cord, testes and
pancreas24. In the pancreas, sox9 expression is associated
with a subset of mitotically active, Notch-responsive pluripo-
tential progenitors25. In the latter context sox9 plays a dual
role in maintaining and regulating a network of transcription
factors that control progenitor cell identity and supporting
cell differentiation within the developing organ26. We be-
lieve that in this context it is unlikely that sox9 exclusively
maintains the progenitor phenotype of clonal isolates from
immature surface-zone chondrocytes.Notch-1 is a single-pass transmembrane receptor that is
activated in a juxtacrine manner by transmembrane ligands
of the Delta/Serrate/LAG-2 (DSL) family27. Notch-1 has
been implicated in the regulation of cell-fate decisions
such as self-renewal in stem cells and differentiation of pro-
genitor cells along a particular lineage. Depending on the
cellular and developmental context the Notch signalling
pathway can act as a regulator of cellular proliferation
and/or cell survival. Previous work has shown that inhibi-
tion of g-secretase-dependent Notch signalling using N-
[N-(3,5-diﬂuorophenacetyl-L-alanyl)]-S-phenylglycine t-butyl
ester (DAPT) results in loss of clonality of progenitor cells
that can be rescued following transfection of an activated
Notch-1 construct. Our motivation to study Notch-1 expres-
sion was spurred by the ﬁnding that it is expressed by sur-
face-zone chondrocytes in immature articular cartilage and
therefore would be predicted to increase in clonal popula-
tions. There was no increase in Notch-1 gene expression
in passaged chondroprogenitors but dedifferentiated full-
depth chondrocytes expressed threefold greater Notch-1
message in comparison, although both cell populations ex-
press equivalent amounts of HES-1 an indirect marker of
Notch signalling activation. A recent study by Karlsson et
al.28 described no correlation between cell size or Notch-1
expression with progenitor status in adult human cartilage,
the same group has also described an increase in Notch-
1 and Jagged-1 expression in OA cartilage29 a ﬁnding
that other studies have correlated with the presence of pro-
liferating clusters of cells that are hypothesised to contain
progenitor-like cells30. Therefore higher expression levels
of Notch-1 appear to negatively correlate with cartilage
health. In support of the latter conclusion, preliminary
analysis of pellet cultures of expanded non-clonal
Fig. 7. Immunolocalisation of aggrecan, Notch-1, PCNA and sox9 proteins in chondroprogenitor cell pellets. (A) Chondroprogenitors grown for
21 days in chondrogenic medium containing ITS-TGFb1. Safranin-O metachromatic staining of pellets revealed a central region with red stain-
ing that was conﬁned to cell nuclei (ringed with white dots) and regions positive for staining for sulphated proteoglycan (orange-red ). Aggrecan
labelling, a marker of differentiated chondrocytes was absent or weakly labelled the central region of the pellet. Notch-1 labelling was detected
in a band of cells bordering undifferentiated and aggrecan positive-differentiated chondroprogenitors. Scale bar¼ 100 mm. PCNA labelling
(arrowed ) was present in cells at the margin between cell-dense and undifferentiated, and differentiated (aggrecan positive) cells in chondro-
progenitor pellets. Propidium iodide (PI) was used to ﬂuorescently label nuclei. We observed intense nuclear labelling with sox9 in undiffer-
entiated chondroprogenitors, nuclei labelled yellow (arrowed ) compared to cells in the peripheral margin (arrowhead ). Scale bar¼ 100 mm.
(B) At higher magniﬁcation, separation of the channels for nuclear (PI) and sox9 (FITC) labelling revealed cytoplasmic and nuclear localisation
for sox9 in peripheral chondrocytes, whereas localisation was predominantly nuclear in cells lying deeper within the cartilage pellet.
Scale bar¼ 50 mm.
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a disorganised morphological structure compared to pellets
produced by clonal chondroprogenitors (notes added in
proof ).
Pellet cultures using clonal chondroprogenitors that had
undergone at least 30 PD resulted in the appearance of
co-ordinated and regulated growth of cartilage, Notch-1 pro-
tein was principally localised to a band of cells in the undif-
ferentiated interior of the pellet, and a band of proliferation
(PCNA positive cells) was seen at the boundary between
overt differentiation into a mature chondrocyte phenotype
marked by aggrecan deposition in the extracellular matrix,
indicating that cell division is associated with transition to
the differentiated phenotype31. Notch-1 regulates mainte-
nance of progenitor cells and it has suppressive effects
on chondrocytic differentiation of mesenchymal stem
cells9,32. Therefore, expression of Notch-1 within the carti-
lage pellets appears to co-ordinate regulated growth and
differentiation of chondroprogenitors. Within the cartilage
pellets sox9 protein levels increased at the boundary be-
tween undifferentiated and differentiated progenitors and
we noted intense nuclear labelling of cells within undifferen-
tiated chondroprogenitors. In differentiated progenitors,
sox9 protein was distributed equally between cytoplasm
and nucleus. From this work and that of others, we deduce
that the subcellular distribution of sox9 is important in chon-
drocyte differentiation. Analysis of clinically relevant sox9
mutations has shown that inhibition of nuclear import is
one mechanism through which normal function is disrup-
ted33. sox9 is found in the cytoplasm in undifferentiated go-
nads. Upon testis differentiation it found exclusively in the
nucleus34 and manipulation of sox9 subcellular localisation
has shown that it functions as a regulatory switch, in this
case, of sex determination33.
A number of studies have implicated dedifferentiated ar-
ticular chondrocytes as a true multipotent primitive popula-
tion35e37. The progenitor phenotype in this class of cells is
thought not to arise as a consequence of differential ampli-
ﬁcation of progenitor cells but through bona fide dedifferen-
tiation of chondrocytes as suggested by Diaz-Romero et al.
for human articular chondrocytes38. Whilst both bovine ar-
ticular chondroprogenitor and dedifferentiated chondrocytes
express low levels of collagen type II and aggrecan, they
are not equivalent. For example, chondroprogenitor cell
lines transiently maintain telomerase activity and have de-
creased Notch-1 expression compared to dedifferentiated
chondrocytes during culture expansion. These types of phe-
notypic differences in cell populations are an important ther-
apeutic consideration as we have shown dedifferentiated
chondrocytes undergo replicative stress and loss of telo-
mere ends much at a faster rate than clonally derived chon-
droprogenitors, and therefore, monoclonally derived
chondrocytes may have advantages in tissue repair and
regeneration.
The surface of neonatal immature bovine articular carti-
lage has a higher cell density than more mature articular
cartilage by approximately 50%39, and whereas surface-
zone cells contain clonogenic cells at a higher frequency
than cells from the middle and deep zones9, this ﬁnding
does not extend to mature tissue where the frequency is
equal for the surface and deep zones, probably reﬂecting
changes growth characteristics of more mature tissue.
Whether clonogenic cells from more mature articular carti-
lage also observe progenitor characteristics consistent
with those found in neonatal surface-zone derived cells
may be critical in determining whether they are therapeuti-
cally useful or not, as the case may be. Thus far, humanarticular chondrocytes from mature tissue have been cloned
and they do show characteristics of the progenitor (dediffer-
entiated) phenotype including differential growth properties
and phenotypic plasticity35,40.
In conclusion, we have shown that clonally derived bo-
vine articular chondroprogenitors undergo rapid growth fol-
lowed by slower linear growth kinetics, have elevated
telomerase activity, maintain their telomere ends though
both processes appear transitory. After extended expansion
in monolayer, equivalent to the production of 1 109 cells
from a single cell, chondroprogenitors can differentiate to
produce cartilage in a co-ordinated manner.Conﬂict of interest
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